Here's what to know about weight loss drugs such as Wegovy and Zepbound. CR helps you decide whether semaglutide or ...

Metabolism shapes daily energy use and weight loss outcomes. Learn about BMR, NEAT, TEF, and how to combine diet, sleep, and ...

CicadaBio today announced that new preclinical data for CC-18, its investigational GLP-1/anti-ActRII dual-pathway fusion ...

By Bhanvi Satija LONDON, June 7 (Reuters) - Boehringer Ingelheim said on Sunday its experimental obesity drug cut visceral ...

Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat ...

What does “GLP-1-friendly” actually mean?

NEW ORLEANS, June 6, 2026 /PRNewswire/ -- Ractigen Therapeutics, a pioneering clinical-stage biotechnology company developing innovative small activating RNA (saRNA) therapeutics, today announced that ...

What if GLP-1s aren’t causing muscle loss at all? New data reveals a massive misinterpretation that could change the entire ...

Weight-loss injections continue to reshape conversations around obesity treatment and metabolic health. Men across different ...

GLP-1 drugs such as Mounjaro are helping millions of people rapidly lose weight. But the changes happening inside the body go far beyond the number on the scale ...

News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP ...

Raleigh and Wilmington Weight Loss Centers introduce a new program this summer to maintain weight loss without relying ...